logo

Exact Sciences Corp. (EXAS)



Trade EXAS now with
  Date
  Headline
2/11/2020 4:09:50 PM Exact Sciences Q4 EPS $0.54 Vs. Loss $0.44 Year Ago
1/12/2020 7:50:25 PM Exact Sciences Expects Q4 Total Revenue Of $294 Mln - $296 Mln, Increase Of 61% From 2018
12/12/2019 6:03:12 AM Exact Sciences Presents New Data From Large Studies Highlights Value Of Oncotype DX Breast Recurrence Score® At SABCS
11/7/2019 2:19:37 PM Genomic Health Stockholders Approve Proposed Acquisition By Exact Sciences
10/14/2019 6:01:19 AM Exact Sciences And Mayo Clinic Initiate 150,000 Patient, 7-Yr Study To Evaluate Real-World Impact Of Cologuard
9/23/2019 5:59:30 AM Exact Sciences Says FDA Approves Cologuard For Use In Younger Americans, Ages 45 To 49
7/29/2019 7:11:00 AM Exact Sciences, Genomic Health To Merge In $2.8 Bln Cash And Stock Deal
7/29/2019 7:09:16 AM Exact Sciences Q2 Net Loss $38.4 Mln Vs Net Loss $36.4 Mln Last Year
3/6/2019 1:08:31 AM Gemalto Unveils Cloud HSM: HSM On Demand For CyberArk, HSM On Demand For Hyperledger And HSM On Demand For Oracle TDE
3/6/2019 12:16:44 AM Exact Sciences Announces Upsizing And Pricing Of 0.3750% Convertible Senior Notes Due 2027
2/21/2019 4:11:13 PM Exact Sciences Q4 Loss/share $0.44 Vs. Loss $0.18 Year Ago
1/7/2019 7:44:56 AM William Blair Reiterates EXACT Sciences Corp. (EXAS) At Outperform
  
 
>